Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Harvard Bioscience (HBIO) Non-cash Items (2019 - 2024)

Harvard Bioscience (HBIO) has disclosed Non-cash Items for 6 consecutive years, with $91000.0 as the latest value for Q2 2024.

Quarterly Non-cash Items changed N/A to $91000.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $91000.0 through Jun 2024, changed N/A year-over-year, with the annual reading at $1.8 million for FY2023, 866.32% up from the prior year.
Non-cash Items for Q2 2024 was $91000.0 at Harvard Bioscience, down from $964000.0 in the prior quarter.
The five-year high for Non-cash Items was $5.6 million in Q4 2021, with the low at $91000.0 in Q2 2024.
Average Non-cash Items over 5 years is $1.9 million, with a median of $1.4 million recorded in 2023.
The sharpest move saw Non-cash Items skyrocketed 870.04% in 2020, then crashed 96.58% in 2022.
Over 5 years, Non-cash Items stood at $2.5 million in 2020, then soared by 122.74% to $5.6 million in 2021, then plummeted by 96.58% to $190000.0 in 2022, then soared by 866.32% to $1.8 million in 2023, then plummeted by 95.04% to $91000.0 in 2024.
According to Business Quant data, Non-cash Items over the past three periods came in at $91000.0, $964000.0, and $1.8 million for Q2 2024, Q1 2024, and Q4 2023 respectively.